The Department of Health and Human Services, specifically BARDA, will be working with Novavax and VaxInnate to develop better vaccine preparedness for pandemics. Contracts worth a total of $215 M were awarded to both companies. Both contracts could increase in value to total as much as $375 M.
The two companies will help the US goverment with next generation flu vaccines that can be produced faster in times of pandemic. Novavax will use its money to support trials of its VLP flu vaccine candidate with a new adjuvant. Novavax is also developing a manufacturing facility plan to allow it to produce vaccine within 12 weeks and at least 50 million doses within six months. VaxInnate will develop technology that combines influenza and bacteria proteins to stimulate strong immune response against the flu. See Fierce Biotech story.
HHS hopes this partnership for pandemic and seasonal flu will prevent it from being caught with it fly down again when it comes time to deliver doses to the public.
- A Flea and a Fly in a Flue
- A flea and a fly in a flue
Were imprisoned, so what could they do?
Said the fly, "let us flee!"
"Let us fly!" said the flea.
So they flew through a flaw in the flue.
--Ogden Nash
Posted by Bruce Lehr March 2nd 2011.
Comments